Moore Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Moore Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,000	Closed	-$1.58M	–	564
2023 Q4	$1.58M	Buy	+5,000	New	+$972K	0.03%	248

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Moore Capital Management's KRTX Position: Q1 2024 in Review

Moore Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5,000 shares — an estimated $1.58M sold.

Moore Capital Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.58M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Moore Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Moore Capital Management sold 5,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.58M.
Moore Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Moore Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.58M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Moore Capital Management's 13F filing for Q1 2024, filed 15 May 2024.